1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NPIPA7 CTRPv2 pan-cancer AAC 0.21 5e-09
mRNA RPS6KA1 CTRPv2 pan-cancer AAC 0.24 5e-09
mRNA PPFIA4 CTRPv2 pan-cancer AAC 0.2 6e-09
mRNA CRMP1 CTRPv2 pan-cancer AAC 0.24 6e-09
mRNA TIFAB CTRPv2 pan-cancer AAC 0.2 7e-09
mRNA ZNF260 CTRPv2 pan-cancer AAC 0.21 7e-09
mRNA RP3-403A15.5 CTRPv2 pan-cancer AAC 0.24 7e-09
mRNA ZNF230 CTRPv2 pan-cancer AAC 0.2 8e-09
mRNA TMEM74 CTRPv2 pan-cancer AAC 0.2 8e-09
mRNA C14orf132 CTRPv2 pan-cancer AAC 0.25 9e-09
Download CSV